📰 Decision Score News
Page 4 - Decision Score News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Decision Score. Real-time updates on events, politics, business and more.
October 19, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today...
October 19, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today...
June 4, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, presented data at the...
April 21, 2021
PreludeDx PREDICT Study Demonstrates High Clinical Utility of DCISionRT for DCIS Breast Cancer Patients 42% change in treatment recommendations when using DCISionRT News provided by Share this article Share this article LAGUNA HILLS, Calif., April 21, 2021 /PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced results for a prospective study in 44 U.S. academic and community cancer centers that eva...
February 23, 2021
GenesisCare and PreludeDx™ Partner to Provide Access to Ground-Breaking Precision Medicine Test for Women With Early-Stage Breast Cancer on February 23 2021 9:00 PM SYDNEY & LAGUNA HILLS, Calif.--(BUSINESS WIRE)--#breastcancerawareness--GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDx TM), a leader in molecular diagnostics and precision medicine, today announced a new strategic partnership aimed at increasing access to personalized breast ...
December 15, 2020
Share this article Share this article LAGUNA HILLS, Calif., Dec. 15, 2020 /PRNewswire/ -- Prelude Corporation (PreludeDxä), a leader in molecular diagnostics and precision medicine for early stage breast cancer, presented clinical outcomes data last week at the San Antonio Breast Cancer Symposium (SABCS) that further validates the DCISionRT® test results of an independent study by Kaiser Permanente Northwest published earlier this year in Clinical Cancer Research. DCISionRT is a biologic ...